Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Paul V Thomas

Showing results (21-30 of 32) with videos related to

Pageof 4
Sort By:
Nature Immunology|October 30, 2021
Low-dose in vivo protection and neutralization across SARS-CoV-2 variants by monoclonal antibody combinationsVincent Dussupt, Rajeshwer S Sankhala, Letzibeth Mendez-Rivera, et al.
Nature Communications|January 3, 2024
Diverse array of neutralizing antibodies elicited upon Spike Ferritin Nanoparticle vaccination in rhesus macaquesRajeshwer S Sankhala, Kerri G Lal, Jaime L Jensen, et al.
NPJ Vaccines|October 29, 2021
A SARS-CoV-2 spike ferritin nanoparticle vaccine protects hamsters against Alpha and Beta virus variant challengeKathryn McGuckin Wuertz, Erica K Barkei, Wei-Hung Chen, et al.
Biorxiv : the Preprint Server for Biology|May 20, 2021
SARS-CoV-2 ferritin nanoparticle vaccines elicit broad SARS coronavirus immunogenicityM Gordon Joyce, Wei-Hung Chen, Rajeshwer S Sankhala, et al.
Biorxiv : the Preprint Server for Biology|June 23, 2021
A SARS-CoV-2 spike ferritin nanoparticle vaccine protects against heterologous challenge with B.1.1.7 and B.1.351 virus variants in Syrian golden hamstersKathryn McGuckin Wuertz, Erica K Barkei, Wei-Hung Chen, et al.
Cell Reports|December 17, 2021
SARS-CoV-2 ferritin nanoparticle vaccines elicit broad SARS coronavirus immunogenicityM Gordon Joyce, Wei-Hung Chen, Rajeshwer S Sankhala, et al.
Biorxiv : the Preprint Server for Biology|April 14, 2021
Efficacy and breadth of adjuvanted SARS-CoV-2 receptor-binding domain nanoparticle vaccine in macaquesHannah A D King, M Gordon Joyce, Ines Elakhal Naouar, et al.
Biorxiv : the Preprint Server for Biology|April 1, 2021
Efficacy of a Broadly Neutralizing SARS-CoV-2 Ferritin Nanoparticle Vaccine in Nonhuman PrimatesMichael G Joyce, Hannah A D King, Ines Elakhal Naouar, et al.
Proceedings of the National Academy of Sciences of the United States of America|September 2, 2021
Efficacy and breadth of adjuvanted SARS-CoV-2 receptor-binding domain nanoparticle vaccine in macaquesHannah A D King, M Gordon Joyce, Ines Lakhal-Naouar, et al.
Science Translational Medicine|December 16, 2021
A SARS-CoV-2 ferritin nanoparticle vaccine elicits protective immune responses in nonhuman primatesM Gordon Joyce, Hannah A D King, Ines Elakhal-Naouar, et al.
Pageof 4

Showing results (21-30 of 32) with videos related to

Sort By:
Pageof 4
Nature Immunology|October 30, 2021
Low-dose in vivo protection and neutralization across SARS-CoV-2 variants by monoclonal antibody combinationsVincent Dussupt, Rajeshwer S Sankhala, Letzibeth Mendez-Rivera, et al.
Nature Communications|January 3, 2024
Diverse array of neutralizing antibodies elicited upon Spike Ferritin Nanoparticle vaccination in rhesus macaquesRajeshwer S Sankhala, Kerri G Lal, Jaime L Jensen, et al.
NPJ Vaccines|October 29, 2021
A SARS-CoV-2 spike ferritin nanoparticle vaccine protects hamsters against Alpha and Beta virus variant challengeKathryn McGuckin Wuertz, Erica K Barkei, Wei-Hung Chen, et al.
Biorxiv : the Preprint Server for Biology|May 20, 2021
SARS-CoV-2 ferritin nanoparticle vaccines elicit broad SARS coronavirus immunogenicityM Gordon Joyce, Wei-Hung Chen, Rajeshwer S Sankhala, et al.
Biorxiv : the Preprint Server for Biology|June 23, 2021
A SARS-CoV-2 spike ferritin nanoparticle vaccine protects against heterologous challenge with B.1.1.7 and B.1.351 virus variants in Syrian golden hamstersKathryn McGuckin Wuertz, Erica K Barkei, Wei-Hung Chen, et al.
Cell Reports|December 17, 2021
SARS-CoV-2 ferritin nanoparticle vaccines elicit broad SARS coronavirus immunogenicityM Gordon Joyce, Wei-Hung Chen, Rajeshwer S Sankhala, et al.
Biorxiv : the Preprint Server for Biology|April 14, 2021
Efficacy and breadth of adjuvanted SARS-CoV-2 receptor-binding domain nanoparticle vaccine in macaquesHannah A D King, M Gordon Joyce, Ines Elakhal Naouar, et al.
Biorxiv : the Preprint Server for Biology|April 1, 2021
Efficacy of a Broadly Neutralizing SARS-CoV-2 Ferritin Nanoparticle Vaccine in Nonhuman PrimatesMichael G Joyce, Hannah A D King, Ines Elakhal Naouar, et al.
Proceedings of the National Academy of Sciences of the United States of America|September 2, 2021
Efficacy and breadth of adjuvanted SARS-CoV-2 receptor-binding domain nanoparticle vaccine in macaquesHannah A D King, M Gordon Joyce, Ines Lakhal-Naouar, et al.
Science Translational Medicine|December 16, 2021
A SARS-CoV-2 ferritin nanoparticle vaccine elicits protective immune responses in nonhuman primatesM Gordon Joyce, Hannah A D King, Ines Elakhal-Naouar, et al.
Pageof 4